- Navigation
- About Us
×About Us
- About Us
- Corporate Responsibility
- Reimbursement Support and Patient Assistance Programs
- Leadership
- Our Work
- Views and Positions
- Our History
- Our People
- Featured Stories
- Merck Honors Research Microbiologist H. Boyd Woodruff, Ph.D.
- Merck Uses Amazon Web Services to Develop Voice-Enabled Solutions
- Cancer Needs Cures. Still.
- Merck Be Well Challenge 2016 — Bringing the Outside In
- A Point of View by Adam Schechter, president of Global Human Health at Merck
- Your Cancer Game Plan
- Merck Foundation Grant Helps Expand Project ECHO
- Merck’s Commitment to Prevention and Care for NCDs
- Meet Jay Schiller
- Merck Research Laboratories Expands into South San Francisco
- Test. Talk. Take. Action.
- Bridging the Gap in Diabetes Care
- World Diabetes Day 2016
- Meet Harriet Johnson
- Merck Employees Surpass Goal of 125,000 Volunteer Hours
- Merck for Mothers Pep Talk
- Meet Commander Adam Scott
- Meet Noreen Rizvi
- Ebola Outbreak
- A Point of View by Dr. Roger Dansey
- A Point of View by Dr. Gregory Lubiniecki
- Merck’s Susan Shiff Selected
- Faces of the Future
- Merck Research Laboratories Honored
- Living with Breast Cancer
- Health Literacy
- A Point of View by Julie Gerberding, M.D., M.P.H.
- Meet Paige Cramer
- Merck Releases 2015/2016 Corporate Responsibility Report
- How Merck Animal Health Helped to Curb a New Strain of CIV
- Women in Science
- 2016 Merck Fellowship for Global Health
- Meet Daria Hazuda
- A Point of View by Dr. Jonathan Cheng
- Understanding Head and Neck Cancer
- HPV Awareness
- Meet Arnaub Chatterjee
- Fasting and Diabetes
- Understanding Diabetes
- Living with Type 2 Diabetes
- It's Personal Series
- Collaborating to Cure
- Meet Mike Thien
- Roy Vagelos Honored by American Heart Association
- Changing the Statistics
- Charting a New Course in Cancer Care
- New Approaches to Fighting Cancer
- May is for Mothers 2016
- Melanoma... 'Never Walk Alone'
- Be Safe In The Sun
- America's Diabetes Challenge
- World Immunization Week
- Merck for Mothers at the Women in the World Summit
- Vaccines: Our History, Our Legacy
- The Impact of Cancer
- Merck’s Commitment to Hepatitis C
- Hepatitis C: A Silent Disease and Growing Concern
- Using Water Wisely
- Meet George W. Merck
- Heart Disease
- Guided by Research, Inspired by Hope
- Why Animal Health Matters
- Merck Turns 125
- Cervical Health Awareness Month
- Rallying to Meet the Need
- William Campbell Wins Nobel Prize
- Meet Christopher Kistler
- Diversity and Inclusion: Good for Business
- Understanding Alzheimer’s Disease
- Living with HIV
- Meet Jason Cheung
- Hepatitis C: A Medical — and Social — Diagnosis
- The Fight Against Hepatitis C
- Saluting Those Who Serve
- Lung Cancer: Challenges and Reasons for Hope
- Real Innovation
- World Diabetes Day
- Lung Cancer
- Refugee and Migrant Relief Efforts
- What is C. difficile
- Beyond Tired? So Are They...
- Meet Alexander Buitrago Santanilla
- Ken Frazier Receives Lifetime Achievement Award
- Merck Employees Walk to End Alzheimer’s
- Ken Frazier at the Clinton Global Initiative
- Helping to Advance a New Set of UN Global Goals
- Merck Fellowship for Global Health
- 2014 Corporate Responsibility Report
- New Therapies to Attack Infections
- The Race Against Resistance
- Identifying the Next Generation of Antibacterial Therapies
- The Fight Against Antimicrobial Resistance
- Mectizan Donation Program
- Meet Paul Reichert
- Merck for Mothers at TEDWomen
- Meet Spencer Dreher
- Merck and HIV/AIDS
- Fasting and Diabetes
- Merck's Rule the Real Talk Campaign
- Meet Daisy Richardson
- Art for All
- MSD in Japan: Bringing Back the Beach
- A Commitment to Diabetes Research
- A Silent Disease and Growing Concern
- Meet Tim Cernak
- Melanoma ... Never Walk Alone
- Be Safe in the Sun
- May is for Mothers
- Bone Health Awareness
- America's Diabetes Challenge
- Pushing to Outpace Superbugs
- The Evolution of Cancer Research
- Parasites and Your Pets
- Meet Ayesha Sitlani
- Every Woman Every Child Event
- Everyday Heroes
- New Approaches to Fighting Cancer
- Insomnia
- Advancing Oncology Research Through Clinical Trials
- Bridging the Gap in Diabetes Care
- Closing the Circle on Rabies
- Desafiando la Diabetes
- Understanding Diabetes
- Helping Empower Women Living with HIV
- Diabetes and Travel
- Vaccines: Our History, Our Legacy
- The Impact of Cancer
- A Point of View by Eric Rubin, M.D.
- Making a Difference
- Inventing For Life
- Products
- Research
- Licensing
- Newsroom
- Careers
- Investors
KEYTRUDA
Download:
KEYTRUDA2.jpg (767.7 KB)Follow Us
@lauriekay21 Thanks for sharing your story, Laurie! We wish your husband the best of luck in the future.-46 min 58 sec ago
Creating a healthy workplace for our employees is just as important to us as creating a healthier society:… https://t.co/sBgtU6I7lG-3 hours 16 min ago
Announcing the Alexa #DiabetesChallenge finalists! 5 voice-enabled solutions that can help improve patients’ lives: https://t.co/75PJMt6TrS-5 hours 13 min ago
Copyright © 2009- Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.
Forward-Looking Statement
Forward-Looking Statement of Merck & Co., Inc., Kenilworth, NJ, USA
This website of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
No Duty to Update
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.
|
Merck Worldwide
Merck, known as MSD outside the United States and Canada, is a leading research-driven healthcare company.